US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
from NDTV News - Topstories https://ift.tt/3bIUCMT
MASIGNASUKAv102
6510051498749449419
comment 0 Comments
more_vert